In Silico Modeling of FDA-approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach

BELLERA C.; SBARAGLINI ML.; ALBERCA L.N.; ALICE J.I; TALEVI A.

In Silico Drug Design

Elservier

Lugar: Amsterdam; Año: 2018; p. 625 - 648

Drug repurposing (i.e., finding new therapeutic uses for already known drugs, including approved, abandoned, discontinued and investigational drugs) is being extensively applied worldwide to expedite the development of novel therapeutic solutions. Such strategy could be particularly relevant in the fields of neglected and rare diseases, where drug development funding is scarce and most of the ongoing research is funded by the public sector or non-for-profit initiatives. In silico tools can make the drug repurposing approach even more cost-efficient. Here, we present an overview of cheminformatic, bioinformatic, text mining and network-based approaches which are currently applied to guide drug repurposing, including virtual screening, target fishing, estimation of molecular determinants of promiscuity, binding site similarity predictions, the similarity ensemble approach, among others. Specific applications of such techniques within the field of neglected conditions are discussed, when available.